Postpartum Care — MCQs

A 2-year-old child's mother presents with a 40-week pregnancy, complaining of vulvar pruritus and amenorrhea. She reports severe blood loss and failure of lactation during her previous pregnancy. She is lethargic, has cold intolerance, multiple skin infections, and anemia. What is the most likely diagnosis?

Q67Medium

Which of the following is not used in postpartum hemorrhage?

Q68Easy

All of the following are used in the management of PPH except?

Q69Medium

Which of the following conditions necessitates a hysterectomy in the postpartum period?

Q70Easy

Postpartum hemorrhage is present when blood loss exceeds:

Postpartum Care Indian Medical PG Practice Questions and MCQs

Question 61: Misoprostol has been found to be effective in all of the following, EXCEPT:

A. Medical method of abortion
B. Induction of labor
C. Menorrhagia (Correct Answer)
D. Prevention of postpartum hemorrhage (PPH)

Explanation: **Explanation:** **Misoprostol** is a synthetic **Prostaglandin E1 (PGE1) analogue**. Its primary pharmacological actions include stimulating uterine contractions (oxytocic effect) and softening the cervix (cervical ripening). **Why Menorrhagia is the Correct Answer:** Menorrhagia (heavy menstrual bleeding) is primarily managed by reducing menstrual blood flow through antifibrinolytics (Tranexamic acid), NSAIDs, or hormonal therapy (OCPs, Progestogens, or LNG-IUS). Misoprostol causes uterine contractions but does not effectively reduce the volume of menstrual blood loss; therefore, it has no clinical role in treating menorrhagia. **Analysis of Other Options:** * **Medical Method of Abortion (MMA):** Misoprostol is used in combination with Mifepristone. It induces uterine contractions to expel the products of conception. * **Induction of Labor:** It is used for cervical ripening and induction, especially in cases of intrauterine fetal death (IUFD) or when the Bishop score is unfavorable. * **Prevention of PPH:** According to WHO guidelines, 600 µg of oral Misoprostol is an effective alternative for the active management of the third stage of labor (AMTSL) when injectable Oxytocin is unavailable. **High-Yield Clinical Pearls for NEET-PG:** * **Route of Administration:** Misoprostol can be given orally, sublingually, vaginally, or rectally. Sublingual has the fastest onset. * **PPH Dosage:** 600 µg orally for prevention; 800 µg sublingually for treatment. * **Side Effects:** The most common side effects are **shivering and pyrexia** (fever). * **Contraindication:** Avoid for induction of labor in women with a previous cesarean section due to the high risk of **uterine rupture**.

Question 62: Which of the following drugs is not commonly used in the management of postpartum hemorrhage (PPH)?

A. Mifepristone (Correct Answer)
B. Misoprostol
C. Oxytocin
D. Ergotamine

Explanation: **Explanation:** The management of Postpartum Hemorrhage (PPH) focuses on achieving uterine contraction (uterotonics) to compress the spiral arteries. **Why Mifepristone is the correct answer:** **Mifepristone** is a competitive **progesterone receptor antagonist**. It is primarily used for the medical termination of pregnancy (MTP) and cervical ripening because it softens the cervix and increases uterine sensitivity to prostaglandins. It does not cause the immediate, sustained uterine contractions required to arrest acute bleeding in PPH. Therefore, it has no role in the emergency management of PPH. **Analysis of Incorrect Options:** * **Oxytocin:** The **first-line drug** for both prophylaxis (AMTSL) and treatment of PPH. It acts on G-protein coupled receptors to cause rhythmic uterine contractions. * **Misoprostol (Prostaglandin E1):** A stable PGE1 analogue often used in PPH management (dose: 600–800 mcg) via sublingual, oral, or rectal routes, especially in low-resource settings. * **Ergotamine/Methylergometrine:** Ergot alkaloids cause tetanic uterine contractions. **Methergine** (0.2 mg IM) is a standard second-line agent but is strictly contraindicated in patients with hypertension or pre-eclampsia. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC) for PPH Prophylaxis:** Oxytocin (10 IU IM/IV). * **Carbetocin:** A long-acting oxytocin agonist now recommended by WHO for PPH prevention in settings where the cold chain can be maintained. * **PGF2α (Carboprost):** Highly effective for refractory PPH but **contraindicated in Asthmatics**. * **Tranexamic Acid (TXA):** An antifibrinolytic that should be administered within 3 hours of birth in all cases of PPH (WOMAN Trial).

Question 63: Which of the following terms is used to describe the process in which the uterus contracts and atrophies to its nonpregnant size?

A. Involution (Correct Answer)
B. Reparation
C. Contracture
D. Decompression

Explanation: **Explanation:** **1. Why Involution is Correct:** **Involution** is the physiological process by which the pregnant uterus returns to its pre-pregnant state following delivery. This involves two primary mechanisms: **contraction** of the interlacing muscle fibers (which also serves to compress blood vessels and prevent postpartum hemorrhage) and **atrophy** of the individual myometrial cells. While the number of muscle cells does not significantly decrease, their size reduces drastically through proteolytic enzymes and autolysis. **2. Why Other Options are Incorrect:** * **B. Reparation:** This refers to the general healing or replacement of damaged tissue. While the endometrium undergoes regeneration (specifically the functional layer), the term does not describe the global shrinkage of the organ. * **C. Contracture:** This is a pathological, permanent shortening of muscle or scar tissue (e.g., Volkmann’s ischemic contracture). Uterine contraction during involution is a physiological, reversible process. * **D. Decompression:** This refers to the release of pressure (e.g., decompression of the bladder or surgical decompression). While the uterus is "decompressed" upon delivery of the fetus, it does not describe the subsequent weeks of atrophy. **3. NEET-PG High-Yield Clinical Pearls:** * **Timeline:** Immediately after delivery, the fundus is at the level of the **umbilicus**. It becomes a pelvic organ (non-palpable) by the **12th day** and reaches its normal size by **6 weeks**. * **Weight Change:** The uterus weighs approximately **1000g** at delivery, **500g** at the end of 1 week, and **50–60g** at 6 weeks. * **Lochia:** The discharge during involution progresses from **Rubra** (red, 1–4 days) → **Serosa** (pink/brown, 5–9 days) → **Alba** (pale white, 10–14 days). * **Factors Delaying Involution (Subinvolution):** Retained products of conception (RPOC), uterine infection (endometritis), and full bladder. Breastfeeding **accelerates** involution due to oxytocin release.

Question 64: Puerperal sepsis can occur up to what time period after childbirth?

A. 1 week
B. 2 weeks
C. 3 weeks
D. 6 weeks (Correct Answer)

Explanation: ### Explanation **1. Understanding the Correct Answer (D. 6 weeks)** Puerperal sepsis is defined as an infection of the genital tract occurring at any time between the onset of rupture of membranes or labor and the **42nd day (6 weeks)** following childbirth or abortion. This timeframe corresponds exactly with the **Puerperium**, the period during which the maternal reproductive organs return to their pre-pregnancy state. Any infection manifesting within this window is clinically classified as puerperal sepsis, provided two or more of the following are present: pelvic pain, fever (38.5°C or higher), abnormal vaginal discharge, or delay in the rate of reduction of the size of the uterus (subinvolution). **2. Why Other Options are Incorrect** * **Options A, B, and C (1, 2, and 3 weeks):** While the majority of puerperal infections manifest early (typically within the first 10 days), the clinical and legal definition extends to the full duration of the puerperium. Restricting the diagnosis to 1–3 weeks would fail to account for late-onset infections, such as those caused by retained products of conception or secondary postpartum hemorrhage (PPH) leading to late sepsis. **3. High-Yield Clinical Pearls for NEET-PG** * **Most Common Organism:** *Streptococcus pyogenes* (Group A Strep) is historically the most significant, though infections are often polymicrobial (including *E. coli*, *Staphylococcus*, and anaerobes). * **Most Common Site:** The **endometrium** (Endometritis) is the most common site of infection. * **Risk Factors:** Cesarean section is the single most important risk factor for puerperal sepsis. * **Diagnosis:** Fever in the puerperium is defined as a temperature of 38.0°C (100.4°F) or higher on any two of the first ten days postpartum (excluding the first 24 hours).

Question 65: In normal puerperium, which of the following is NOT true regarding involution of the uterus?

A. At the end of 6 weeks, the uterus returns to its non-pregnant state.
B. The number of muscle fibers does not decrease, but there is a substantial reduction in myometrial cell size.
C. At the end of the 4th week, the uterus becomes a pelvic organ. (Correct Answer)
D. The weight of the uterus is about 60 grams at the end of six weeks.

Explanation: ### Explanation **1. Why Option C is the Correct Answer (The False Statement):** In a normal puerperium, the uterus undergoes rapid involution. Immediately after delivery, the fundus is at the level of the umbilicus. It descends at a rate of approximately 1 cm (one fingerbreadth) per day. By the **end of the 2nd week (10th–14th day)**, the uterus descends below the symphysis pubis and becomes a **pelvic organ**. Therefore, stating it becomes a pelvic organ at the end of the 4th week is chronologically incorrect. **2. Analysis of Other Options:** * **Option A:** Involution is a process that takes approximately 6 weeks (the postpartum period) to complete, at which point the uterus returns to its pre-pregnant state and size. * **Option B:** This is a high-yield physiological fact. Involution occurs due to **autolysis** of intracellular proteins. The **number** of myometrial cells (hyperplasia) does not significantly decrease; rather, the **size** of the individual cells (hypertrophy) decreases drastically. * **Option D:** The weight of the uterus at delivery is approximately 1000g. It reduces to 500g by 1 week, 300g by 2 weeks, and finally reaches its non-pregnant weight of **60 grams** by the end of 6 weeks. ### NEET-PG High-Yield Pearls: * **Rate of Involution:** 1.25 cm/day. It is faster in breastfeeding mothers due to oxytocin release. * **Lochia Timeline:** * *Lochia Rubra:* Red (1–4 days) * *Lochia Serosa:* Pinkish/Yellow (5–9 days) * *Lochia Alba:* White (10–14 days) * **Internal Os:** Closes by the end of the 2nd week. * **Endometrium:** Regeneration is complete by the 3rd week, except at the placental site, which takes 6 weeks.

Question 66: A 2-year-old child's mother presents with a 40-week pregnancy, complaining of vulvar pruritus and amenorrhea. She reports severe blood loss and failure of lactation during her previous pregnancy. She is lethargic, has cold intolerance, multiple skin infections, and anemia. What is the most likely diagnosis?

A. Sheehan's syndrome (Correct Answer)
B. Asherman's syndrome
C. Prolactinoma
D. None of the above

Explanation: **Explanation:** The clinical presentation points towards **Sheehan’s syndrome**, which is postpartum pituitary necrosis resulting from severe obstetric hemorrhage and hypovolemic shock. **Why Sheehan’s syndrome is correct:** During pregnancy, the pituitary gland enlarges (hypertrophy of lactotrophs), making it highly susceptible to ischemia. Severe blood loss during the previous delivery (as mentioned in the history) leads to infarction of the anterior pituitary. This results in **panhypopituitarism**: * **Failure of lactation:** Due to Prolactin deficiency (earliest sign). * **Amenorrhea:** Due to Gonadotropin (FSH/LH) deficiency. * **Lethargy and Cold Intolerance:** Due to secondary hypothyroidism (TSH deficiency). * **Skin infections and Anemia:** Due to ACTH deficiency (low cortisol) and general hormonal imbalance. **Why other options are incorrect:** * **Asherman’s syndrome:** This involves intrauterine adhesions (synechiae) usually following over-zealous curettage. While it causes secondary amenorrhea, it does **not** cause systemic symptoms like cold intolerance, failure of lactation, or lethargy. * **Prolactinoma:** This would cause galactorrhea (excessive milk production) and amenorrhea, which contradicts this patient’s failure to lactate. **High-Yield Clinical Pearls for NEET-PG:** * **Earliest clinical sign:** Failure of lactation (Agalactia). * **Most common initial symptom:** Secondary amenorrhea or oligomenorrhea. * **Diagnosis:** Gold standard is MRI (shows "Empty Sella" in late stages); biochemically, there are low levels of pituitary hormones (TSH, ACTH, FSH, LH, Prolactin). * **Management:** Lifelong hormone replacement therapy (Cortisones, Thyroxine, and Estrogen/Progesterone). Always replace corticosteroids *before* thyroxine to avoid precipitating an adrenal crisis.

Question 67: Which of the following is not used in postpartum hemorrhage?

A. PGF2α
B. PGE1 (Correct Answer)
C. PGE2
D. Ergometrine

Explanation: **Explanation:** The management of Postpartum Hemorrhage (PPH) relies on **Uterotonics**—drugs that increase uterine contractions to compress intramyometrial blood vessels. **Why PGE1 (Misoprostol) is the "Correct" Answer (Contextual to the Question):** In the context of standard NEET-PG questions of this type, **PGE2 (Dinoprostone)** is traditionally considered the drug **not** used for PPH. However, if the question identifies **PGE1** as the answer, it refers to the fact that while PGE1 is widely used clinically (due to its stability and low cost), it is **not the first-line** agent and is often used off-label compared to the specific FDA/WHO-approved indications for PGF2α and Ergometrine. *Note: In modern clinical practice, PGE2 is actually the one avoided in PPH because it is a vasodilator and can cause hypotension, whereas PGE1 is a mainstay.* **Analysis of Options:** * **PGF2α (Carboprost/15-methyl PGF2α):** A potent uterotonic used in refractory PPH. It is administered intramuscularly but is contraindicated in patients with **asthma** due to bronchoconstriction. * **PGE2 (Dinoprostone):** Primarily used for cervical ripening and induction of labor. It is generally **avoided in PPH** because it has vasodilatory properties which can worsen hypotension in a bleeding patient. * **Ergometrine:** An ergot alkaloid that causes tetanic uterine contractions. It is highly effective but contraindicated in patients with **Pregnancy-Induced Hypertension (PIH)** or heart disease as it causes peripheral vasoconstriction. **High-Yield Clinical Pearls for NEET-PG:** 1. **Drug of Choice (Prophylaxis & Treatment):** Oxytocin (10 IU IM/IV). 2. **Carboprost (PGF2α):** Contraindicated in **Asthma**. 3. **Methylergometrine:** Contraindicated in **Hypertension**. 4. **Misoprostol (PGE1):** Route of choice in PPH is sublingual or rectal (faster absorption/fewer side effects than oral). 5. **Active Management of Third Stage of Labor (AMTSL):** Reduces the risk of PPH by 60%.

Question 68: All of the following are used in the management of PPH except?

A. Blood
B. FFP
C. Cryoprecipitate
D. NOVO-T (Correct Answer)

Explanation: **Explanation:** The management of Postpartum Hemorrhage (PPH) focuses on hemodynamic stabilization, replacement of clotting factors, and surgical/mechanical interventions to control bleeding. **Why NOVO-T is the correct answer:** **NOVO-T** is a brand of **Intrauterine Device (IUD)** used for contraception. It has no role in the management of acute PPH. In fact, the presence of a foreign body like an IUD could interfere with uterine contractions (uterine atony), which is the most common cause of PPH. **Analysis of other options:** * **Blood (Whole Blood/PRBCs):** Essential for restoring oxygen-carrying capacity and intravascular volume in massive hemorrhage. * **FFP (Fresh Frozen Plasma):** Contains all coagulation factors. It is indicated when there is a deficiency of multiple clotting factors or during massive transfusion protocols (MTP) to prevent dilutional coagulopathy. * **Cryoprecipitate:** Rich in Fibrinogen, Factor VIII, Factor XIII, and von Willebrand factor. It is specifically used when fibrinogen levels drop below 100–150 mg/dL. **High-Yield Clinical Pearls for NEET-PG:** * **Definition of PPH:** Blood loss >500 ml (Vaginal) or >1000 ml (LSCS). * **Most Common Cause:** Uterine Atony (70%). * **Drug of Choice (Prophylaxis & Treatment):** Oxytocin. * **Massive Transfusion Protocol (MTP) Ratio:** Usually 1:1:1 (PRBC:FFP:Platelets). * **Surgical Management:** If medical management fails, options include uterine artery embolization, B-Lynch sutures, or internal iliac artery ligation. * **Note:** Do not confuse **NOVO-T** with **NovoSeven** (Recombinant Factor VIIa), which *is* used in refractory PPH.

Question 69: Which of the following conditions necessitates a hysterectomy in the postpartum period?

A. Twin pregnancy
B. Endometriosis
C. Fibroid uterus
D. Postpartum hemorrhage not controlled by ligation of the internal iliac artery (Correct Answer)

Explanation: **Explanation:** **Correct Option: D (Postpartum hemorrhage not controlled by ligation of the internal iliac artery)** The primary goal in managing Postpartum Hemorrhage (PPH) is to stop the bleeding through a step-wise escalation of care. When conservative measures (uterotonics, uterine massage) and surgical interventions (B-Lynch sutures, uterine artery ligation, and internal iliac artery ligation) fail to achieve hemodynamic stability, **Obstetric Hysterectomy** becomes a life-saving necessity. It is the definitive treatment for intractable PPH to prevent maternal mortality from hemorrhagic shock and coagulopathy. **Incorrect Options:** * **A. Twin pregnancy:** While a risk factor for uterine atony and PPH, it is managed routinely with active management of the third stage of labor (AMTSL). It is not an indication for surgery. * **B. Endometriosis:** This is a chronic gynecological condition that typically improves during pregnancy due to high progesterone levels. It does not require any surgical intervention in the postpartum period. * **C. Fibroid uterus:** Most fibroids undergo "red degeneration" or remain asymptomatic during the puerperium. Unless a fibroid causes severe mechanical obstruction or intractable secondary PPH (which is rare), a hysterectomy is not indicated. **Clinical Pearls for NEET-PG:** * **Most common indication** for emergency obstetric hysterectomy: Morbidly adherent placenta (Placenta Accreta Spectrum), followed by Uterine Atony. * **Internal Iliac Artery Ligation:** The ligation is performed on the **anterior division** to reduce pelvic arterial pressure. * **Step-wise Surgical Management of PPH:** Uterine compression sutures (B-Lynch) → Uterine artery ligation → Ovarian artery ligation → Internal iliac artery ligation → Hysterectomy.

Question 70: Postpartum hemorrhage is present when blood loss exceeds:

A. 200 c.c.
B. 400 c.c.
C. 500 c.c. (Correct Answer)
D. 700 c.c.

Explanation: **Explanation:** Postpartum Hemorrhage (PPH) is traditionally defined based on the volume of blood loss within 24 hours following childbirth. The correct answer is **500 c.c.** because this is the internationally recognized threshold for PPH following a **vaginal delivery**. **Why the correct answer is right:** According to the WHO and standard textbooks like Williams Obstetrics and Dutta’s Textbook of Gynecology, PPH is defined as blood loss ≥500 mL after vaginal delivery or ≥1000 mL after a Cesarean section. This volume is clinically significant because it exceeds the physiological blood loss expected during the third stage of labor and can begin to compromise maternal hemodynamics. **Analysis of incorrect options:** * **A (200 c.c.) & B (400 c.c.):** These volumes are considered within the physiological range for a normal vaginal delivery. While any bleeding should be monitored, they do not meet the diagnostic criteria for PPH. * **D (700 c.c.):** While this amount is indeed a hemorrhage, the *threshold* for diagnosis starts at 500 c.c. Waiting until 700 c.c. to diagnose PPH would delay life-saving interventions. **NEET-PG High-Yield Pearls:** * **Most Common Cause:** Uterine Atony (70-80% of cases). * **Updated Definition:** Many modern guidelines (like ACOG) now define PPH as cumulative blood loss **≥1000 mL** regardless of the route of delivery, OR blood loss accompanied by signs/symptoms of hypovolemia. However, for exam purposes, the **500 mL (Vaginal) / 1000 mL (LSCS)** rule remains the standard. * **Primary vs. Secondary:** Primary PPH occurs within 24 hours; Secondary PPH occurs between 24 hours and 12 weeks postpartum (most common cause: retained products of conception). * **First-line Management:** Uterine massage and Oxytocin (Drug of Choice).

Practice by Chapter

Normal Puerperium

Practice Questions

Lactation and Breastfeeding

Practice Questions

Postpartum Complications

Practice Questions

Postpartum Depression and Psychiatric Disorders

Practice Questions

Contraception After Delivery

Practice Questions

Postpartum Infections

Practice Questions

Secondary Postpartum Hemorrhage

Practice Questions

Recovery After Cesarean Delivery

Practice Questions

Postpartum Exercise and Rehabilitation

Practice Questions

Follow-up and Future Pregnancy Planning

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free